Belluscura shares jumped in opening trade on Tuesday after the portable oxygen unit company said they had signed an agreement with McKesson Medical-Surgical, a division of McKesson.
McKesson is the world’s largest drug distribution company and the 9th largest company by revenue in the US. Belluscura’s X-PLOR® portable oxygen concentrator is now available through McKesson Medical-Surgical’s online distribution channels.
Belluscura shares were over 9% higher at the time of writing on Tuesday.
“We are very pleased that McKesson, one of the largest distributors of pharmaceuticals and medical devices in North America, has chosen the X-PLOR to be offered through their catalogue,” said Robert Rauker, Chief Executive Officer, Belluscura plc.
“This significant distribution agreement will mean that more Americans can purchase our devices throughout the country, broadening our product distribution and making supplemental oxygen more easily accessible.”
Belluscura was founded and subsequently floated on AIM by Tekcapital, who retain an 11% stake in the company.
Tekcapital’s portfolio companies include Belluscura, MicroSalt, Innovative Eyewear and Guident. MicroSalt appointed Zeus Capital as their NOMAD for an AIM listing in late 2022.